The Pathophysiological Basis of Diabetic Cardiomyopathy Development

Area of Science:

• Cardiology
• Endocrinology
• Metabolic Disorders

Background:

• Diabetes mellitus (DM) is linked to significant cardiovascular complications.
• Metabolic dysregulation, including hyperglycemia, insulin resistance, and dyslipidemia, underlies cardiac dysfunction in DM.
• Key pathological pathways involve lipotoxicity, oxidative stress, and advanced glycation end (AGE) product formation.

Purpose of the Study:

• To review the cardiovascular alterations in patients with diabetes mellitus.
• To elucidate the molecular mechanisms linking metabolic disorders to cardiac dysfunction in DM.

Main Methods:

• Literature review of pathophysiological changes in the diabetic myocardium.
• Analysis of metabolic pathways affected by hyperglycemia and insulin resistance.
• Examination of cellular and molecular events leading to cardiac dysfunction.

Main Results:

• Metabolic disorders in DM induce lipotoxicity, oxidative stress (ROS), and AGE formation in the heart.
• These factors contribute to mitochondrial and endoplasmic reticulum dysfunction, ATP deficiency, and calcium stress.
• Chronic inflammation, diastolic and systolic dysfunction, and myocardial fibrosis are consequences of these processes.

Conclusions:

• Diabetes mellitus profoundly impacts myocardial structure and function.
• A complex interplay of metabolic, oxidative, and inflammatory pathways drives diabetic cardiomyopathy.
• Understanding these mechanisms is crucial for managing cardiovascular complications in DM.